MICAL2
[F-actin]-monooxygenase MICAL2
Also known as: FLJ14966, KIAA0750, MICA2_HUMAN, MICALCL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94851
- Gene
- MICAL2
- Ensembl
- ENSG00000133816
- Chromosome
- 11
- Canonical length
- 1957 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a monooxygenase that enhances depolymerization of F-actin and is therefore involved in cytoskeletal dynamics. The encoded protein is a regulator of the SRF signaling pathway. Increased expression of this gene has been associated with cancer progression and metastasis. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
1957 residues, UniProt reviewed canonical sequence.
>O94851|MICAL2
1 MGENEDEKQA QAGQVFENFV QASTCKGTLQ AFNILTRHLD LDPLDHRNFY SKLKSKVTTW
61 KAKALWYKLD KRGSHKEYKR GKSCTNTKCL IVGGGPCGLR TAIELAYLGA KVVVVEKRDS
121 FSRNNVLHLW PFTIHDLRGL GAKKFYGKFC AGSIDHISIR QLQLILFKVA LMLGVEIHVN
181 VEFVKVLEPP EDQENQKIGW RAEFLPTDHS LSEFEFDVII GADGRRNTLE GFRRKEFRGK
241 LAIAITANFI NRNSTAEAKV EEISGVAFIF NQKFFQDLKE ETGIDLENIV YYKDCTHYFV
301 MTAKKQSLLD KGVIINDYID TEMLLCAENV NQDNLLSYAR EAADFATNYQ LPSLDFAMNH
361 YGQPDVAMFD FTCMYASENA ALVRERQAHQ LLVALVGDSL LEPFWPMGTG CARGFLAAFD
421 TAWMVKSWNQ GTPPLELLAE RESLYRLLPQ TTPENINKNF EQYTLDPGTR YPNLNSHCVR
481 PHQVKHLYIT KELEHYPLER LGSVRRSVNL SRKESDIRPS KLLTWCQQQT EGYQHVNVTD
541 LTTSWRSGLA LCAIIHRFRP ELINFDSLNE DDAVENNQLA FDVAEREFGI PPVTTGKEMA
601 SAQEPDKLSM VMYLSKFYEL FRGTPLRPVD SWRKNYGENA DLSLAKSSIS NNYLNLTFPR
661 KRTPRVDGQT GENDMNKRRR KGFTNLDEPS NFSSRSLGSN QECGSSKEGG NQNKVKSMAN
721 QLLAKFEEST RNPSLMKQER RVSGIGKPVL CSSSGPPVHS CCPKPEEATP SPSPPLKRQF
781 PSVVVTGHVL RELKQVSAGS ECLSRPWRAR AKSDLQLGGT ENFATLPSTR PRAQALSGVL
841 WRLQQVEEKI LQKRAQNLAN REFHTKNIKE KAAHLASMFG HGDFPQNKLL SKGLSHTHPP
901 SPPSRLPSPD PAASSSPSTV DSASPARKEK KSPSGFHFHP SHLRTVHPQL TVGKVSSGIG
961 AAAEVLVNLY MNDHRPKAQA TSPDLESMRK SFPLNLGGSD TCYFCKKRVY VMERLSAEGH
1021 FFHRECFRCS ICATTLRLAA YTFDCDEGKF YCKPHFIHCK TNSKQRKRRA ELKQQREEEA
1081 TWQEQEAPRR DTPTESSCAV AAIGTLEGSP PDEPTSPKRP KSISEPQHSD AEGDAASPLP
1141 SEWTSVRISP GEEAAGQDVL AVRVLVTSED SSSDTESDYG GSEGSHTEPC EEKPWRPGSP
1201 HLPHTSLGEA LSRAVSPQCP EEPRAVHAAL QRANSFQSPT PSKYQNWRRE FWWSLTPVNK
1261 RTMSPPKDPS PSLPLPSSSS HSSSPPSSSS TSVSGNAPDG SSPPQMTASE PLSQVSRGHP
1321 SPPTPNFRRR AVAQGAPREI PLYLPHHPKP EWAEYCLVSP GEDGLSDPAE MTSDECQPAE
1381 APLGDIGSNH RDPHPIWGKD RSWTGQELSP LAGEDREKGS TGARKEEEGG PVLVKEKLGL
1441 KKLVLTQEQK TMLLDWNDSI PESVHLKAGE RISQKSAENG RGGRVLKPVR PLLLPRAAGE
1501 PLPTQRGAQE KMGTPAEQAQ GERNVPPPKS PLRLIANAIR RSLEPLLSNS EGGKKAWAKQ
1561 ESKTLPAQAC TRSFSLRKTN SNKDGDQHSP GRNQSSAFSP PDPALRTHSL PNRPSKVFPA
1621 LRSPPCSKIE DVPTLLEKVS LQENFPDASK PPKKRISLFS SLRLKDKSFE SFLQESRQRK
1681 DIRDLFGSPK RKVLPEDSAQ ALEKLLQPFK STSLRQAAPP PPPPPPPPPP PPTAGGADSK
1741 NFPLRAQVTE ASSSASSTSS SSADEEFDPQ LSLQLKEKKT LRRRKKLEKA MKQLVKQEEL
1801 KRLYKAQAIQ RQLEEVEERQ RASEIQGVRL EKALRGEADS GTQDEAQLLQ EWFKLVLEKN
1861 KLMRYESELL IMAQELELED HQSRLEQKLR EKMLKEESQK DEKDLNEEQE VFTELMQVIE
1921 QRDKLVDSLE EQRIREKAED QHFESFVFSR GCQLSRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MICAL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 138 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 138 nTPM
- cerebral cortex: 47 nTPM
- heart muscle: 47 nTPM
- smooth muscle: 44 nTPM
- testis: 43 nTPM
- blood vessel: 29 nTPM
Single-cell type
- choroid plexus epithelial cells: 659 nCPM
- sertoli cells: 487 nCPM
- alveolar cells type 2: 475 nCPM
- alveolar cells type 1: 425 nCPM
- late spermatids: 409 nCPM
- colonocytes: 371 nCPM
Immune cell
- neutrophil: 12 nTPM
- classical monocyte: 7.4 nTPM
- myeloid DC: 5.9 nTPM
- NK-cell: 4 nTPM
- MAIT T-cell: 2.6 nTPM
- total PBMC: 2.6 nTPM
Brain region
- choroid plexus: 231 nTPM
- cerebellum: 229 nTPM
- hippocampal formation: 183 nTPM
- cerebral cortex: 178 nTPM
- white matter: 137 nTPM
- amygdala: 112 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.79
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament depolymerization
- cytoskeleton organization
- heart development
- heart looping
- positive regulation of transcription by RNA polymerase II
- sulfur oxidation
Molecular functions
- actin binding
- F-actin monooxygenase activity
- FAD binding
- metal ion binding
- mitogen-activated protein kinase binding
- monooxygenase activity
- NAD(P)H oxidase H2O2-forming activity
- oxidoreductase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Calponin homology domain
- Zinc finger, LIM-type
- FAD-binding domain
- bMERB domain
- FAD/NAD(P)-binding domain superfamily
- CH domain superfamily
- F-actin Monooxygenase Mical
- [F-actin]-monooxygenase MICAL1-3-like, Rossman domain
- Calponin homology (CH) domain
- LIM domain
- FAD binding domain
- Bivalent Mical/EHBP Rab binding domain
- Mical, Rossman domain
- ProQ/FinO domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MICAL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MICAL2 as an antibody target. Whether an autoantibody or antibody against MICAL2 could matter depends on whether native MICAL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MICAL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MICAL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...